ASO Author Reflections: The Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Non-small Cell Lung Cancer Patients
- PMID: 38573442
- DOI: 10.1245/s10434-024-15243-7
ASO Author Reflections: The Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Non-small Cell Lung Cancer Patients
Similar articles
-
Current status of mediastinal lymph node dissection versus sampling in non-small cell lung cancer.Thorac Surg Clin. 2013 Aug;23(3):349-56. doi: 10.1016/j.thorsurg.2013.05.002. Epub 2013 Jul 16. Thorac Surg Clin. 2013. PMID: 23931018 Review.
-
Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Patients with Stage III-N2 Non-small Cell Lung Cancer.Ann Surg Oncol. 2024 Aug;31(8):5028-5037. doi: 10.1245/s10434-024-15184-1. Epub 2024 Mar 23. Ann Surg Oncol. 2024. PMID: 38520577
-
Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.Ann Thorac Surg. 2009 Apr;87(4):1014-22. doi: 10.1016/j.athoracsur.2008.12.053. Ann Thorac Surg. 2009. PMID: 19324121
-
Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.Ann Thorac Surg. 2006 Jan;81(1):292-7. doi: 10.1016/j.athoracsur.2005.06.077. Ann Thorac Surg. 2006. PMID: 16368383
-
The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement.J Natl Compr Canc Netw. 2012 May;10(5):599-613. doi: 10.6004/jnccn.2012.0062. J Natl Compr Canc Netw. 2012. PMID: 22570291 Review.
References
-
- Zheng H, Hu X-F, Jiang G-N, et al. Define relative incomplete resection by highest mediastinal lymph node metastasis for non-small cell lung cancers: rationale based on prognosis analysis. Lung Cancer. 2011;72(3):348–54. https://doi.org/10.1016/j.lungcan.2010.10.003 . - DOI - PubMed
-
- Edwards JG, Chansky K, Van Schil P, et al. The IASLC lung cancer staging project: analysis of resection margin status and proposals for residual tumor descriptors for non-small cell lung cancer. J Thorac Oncol. 2020;15(3):344–59. https://doi.org/10.1016/j.jtho.2019.10.019 . - DOI - PubMed
-
- Osarogiagbon RU, Faris NR, Stevens W, et al. beyond margin status: population-based validation of the proposed international association for the study of lung cancer residual tumor classification recategorization. J Thorac Oncol. 2020;15(3):371–82. https://doi.org/10.1016/j.jtho.2019.11.009 . - DOI - PubMed
-
- Yun JK, Lee GD, Choi S, et al. A validation study of the recommended change in residual tumor descriptors proposed by the international association for the study of lung cancer for patients with pN2 NSCLC. J Thorac Oncol. 2021;16(5):817–26. https://doi.org/10.1016/j.jtho.2021.01.1621 . - DOI - PubMed
-
- Liu JH, Shi ZH, Cao BJ, Wang Z, Zhang N, Liu J. The prognostic significance of the highest mediastinal lymph node involvement in patients with stage III-N2 non-small cell lung cancer. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15184-1 . - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Medical